Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the efficacy of LY3009104 as assessed by the aggregate proportion of patients in the 4 mg and 8 mg dose groups who achieve an ACR20 response compared to placebo over 12 weeks in patients with active RA despite ongoing MTX therapy.
Inclusion criteria
- Rheumatoid Arthritis